BioCardia (NASDAQ: BCDA) director Form 3 shows no securities owned

Rhea-AI Filing Summary

BioCardia, Inc. filed an initial ownership report showing no securities held by the reporting director. A Form 3 was filed for an individual who serves as a director of BioCardia, Inc. (ticker BCDA) for an event dated 12/02/2025. The filing indicates that the form is filed by one reporting person and includes a remark stating that no securities are beneficially owned. An Exhibit 24 power of attorney is referenced, authorizing the signatory to sign on behalf of the reporting person.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Slosman Marvin

(Last) (First) (Middle)

C/O BIOCARDIA, INC.

320 SOQUEL WAY

(Street)

SUNNYVALE CA 94085

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/02/2025

3. Issuer Name and Ticker or Trading Symbol
BioCardia, Inc. [ BCDA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 – Power of Attorney

No securities are beneficially owned.

	/s/ David McClung, by power of attorney	12/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does BioCardia (BCDA) disclose in this Form 3 filing?

The Form 3 shows that a reporting person who is a director of BioCardia, Inc. currently has no beneficial ownership of the company’s securities according to the filing.

What is the event date reported in BioCardia (BCDA)'s Form 3?

The Form 3 lists the Date of Event Requiring Statement as 12/02/2025.

What is the relationship of the reporting person to BioCardia (BCDA)?

The reporting person is identified as a director of BioCardia, Inc., with that box checked on the form.

Does the reporting person own any BioCardia (BCDA) securities in this Form 3?

No. The remarks section explicitly states: “No securities are beneficially owned.”

Is the BioCardia (BCDA) Form 3 filed by one or multiple reporting persons?

The box for “Form filed by One Reporting Person” is checked, indicating a single reporting person.

What additional document is referenced in this BioCardia (BCDA) Form 3?

The remarks reference Exhibit 24 – Power of Attorney, indicating that the signatory is acting under a power of attorney for the reporting person.